Evidence map›Paper›PMID 38338271›Full record

ArticleHealthcare (Basel, Switzerland)2024

Health Professionals' Perspectives on Commercially Available Intravenous Nutrient Therapies: A Preliminary Report.

Monika Karasiewicz, Agnieszka Lipiak, Paulina Jóźwiak, Bogusz Giernaś, Mateusz Cofta, Ewelina Chawłowska

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Monika KarasiewiczLaboratory of International Health, Department of Preventive Medicine, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland.ORCID 0000-0002-8373-037X
Agnieszka LipiakLaboratory of International Health, Department of Preventive Medicine, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland.ORCID 0000-0002-1826-2901
Paulina JóźwiakDepartment of Preventive Medicine, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland.
Bogusz GiernaśLaboratory of International Health, Department of Preventive Medicine, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland.
Mateusz CoftaLaboratory of International Health, Department of Preventive Medicine, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland.
Ewelina ChawłowskaLaboratory of International Health, Department of Preventive Medicine, Poznan University of Medical Sciences, Święcickiego 6, 60-781 Poznań, Poland.ORCID 0000-0002-1966-9498
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntravenous nutrient therapies (IVNTs) have gained popularity on the commercial market. Targeted at people with a variety of ailments and needs, the procedures allegedly offer numerous benefits and quick results, widely advertised on the websites of drip bars and health clinics as well as in the available literature. What is less often presented is the point of view of the customers of such services and the opinions of health personnel. Although the latter perspective seems to be crucial, little is known about it. Therefore, the purpose of this study was to present the opinions and experiences of health professionals (

methodsThe study was conducted between April 2019 and March 2020 by means of a survey using an ad hoc questionnaire made available mainly to health professionals attending public health postgraduate courses at the Poznan University of Medical Sciences, Poland.

resultsAs many as 91.5% of the respondents had heard of commercially available IVNTs (mostly from the media), and 47.3% knew of a facility offering such services. Among the possible situations where the use of IVNTs would be justified, the most commonly mentioned was a diagnosed nutrient deficiency (37.8%), while the least common ones were libido problems (1.1%) and the need to speed up metabolism (2.1%). For 25.5% of the respondents, there was no good rationale for using IVNTs. As many as 15.4% had no opinion on the subject. Health risks of IVNTs were recognised by 95.2% of professionals, with the biggest concerns being the lack of full information on patients' health status and medical contraindications (84%), the risk of overdose and interactions (77.1%), and hypersensitivity or allergic reactions (75.5%). Among the reasons for IVNTs' popularity, the respondents listed not only fads spread by celebrities and social media (89.4%) and the need for quick, effortless remedies (77.1%), but also reasons inherent in the Polish healthcare system. As many as 80.3% of the respondents stressed the need for public health institutions to take a stand on commercial IVNTs. Knowing of an IVNT facility was not significantly associated with the opinions of professionals in key areas.

conclusionPostgraduate public health courses are a good opportunity to engage health professionals in discussions about the current challenges, trends, and needs in the area of health promotion and healthcare. This study's findings shed some light on the opinions about IVNTs held by health professionals, who are important stakeholders of the healthcare system. Thus, these findings may help to better understand the popularity of IVNTs and incorporate health professionals' perspectives in future efforts aiming to increase the awareness of IVNT-related health risks among both professionals and patients.

Indexed as

alternative therapieshealth professionalsintravenous nutrient therapiesIVNTnutrient cocktailsPolandpublic healthvitamin drips

Identifiers

PMID38338271
PMCPMC10855962
OpenAlexW4391470077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.